What is Benign Prostatic Hyperplasia ?
Benign prostatic hyperplasia (BPH) — also called benign
enlargement of the prostate — is a non-cancerous increase in the size of the
prostate gland that commonly occurs in ageing men.
The prostate is a small gland located below the bladder and
around the urethra (the tube that carries urine out of the body). In BPH, the
prostate gradually enlarges and can press on the urethra, making it harder to
pass urine.
Causes / Risk factors of BPH
The exact cause is not completely known, but these factors
increase the chance of developing BPH:
1. Ageing (most important)
- Rare
before age 40.
- Common
after age 50.
- Frequency
increases with advancing age.
2. Hormonal changes
- Changes
in testosterone and dihydrotestosterone (DHT) levels with ageing.
- DHT
stimulates growth of prostate tissue.
3. Family history
- Having
a father or brother with BPH increases risk.
4. Obesity
- Excess
body weight is associated with larger prostate size and worse symptoms.
5. Diabetes and metabolic syndrome
- Insulin
resistance and metabolic changes may contribute to prostate growth.
6. Lack of physical activity
- Sedentary
lifestyle is linked with higher risk.
7. Cardiovascular disease and hypertension
- Men
with heart disease or high blood pressure may have a higher incidence of
BPH.
8. Chronic inflammation of the prostate
- Long-term
inflammation may play a role in some men.
9. Diet
- Diets
high in saturated fat and low in fruits and vegetables may be associated
with increased risk, though evidence is not completely conclusive.
Symptoms of BPH
Symptoms are mainly urinary symptoms and are often divided
into storage and voiding symptoms.
A. Storage symptoms (bladder symptoms)
- Frequent
urination during the day
- Nocturia
(waking at night to pass urine)
- Urgency
– sudden strong urge to urinate
- Urge
leakage or occasional incontinence
B. Voiding symptoms (passing urine)
- Difficulty
starting urination (hesitancy)
- Weak
urine stream
- Slow
urine flow
- Intermittent
stream (stops and starts)
- Straining
to pass urine
- Dribbling
at the end of urination
- Prolonged
time to empty the bladder
C. After urination
- Feeling
that the bladder has not emptied completely
- Post-void
dribbling (urine leakage after finishing)
Symptoms that suggest complications
Seek medical attention if you develop:
- Sudden
inability to pass urine (acute urinary retention)
- Severe
lower abdominal pain with a full bladder
- Blood
in urine
- Fever
with urinary symptoms
- Recurrent
urinary tract infections
- Bladder
stones
- Swelling
of legs, reduced urine output, or signs of kidney problems
Early vs late symptoms
|
Early |
Later / more severe |
|
Frequency |
Very weak stream |
|
Nocturia |
Straining |
|
Urgency |
Intermittent flow |
|
Mild hesitancy |
Incomplete emptying |
|
Occasional dribbling |
Urinary retention |
Line of treatment of Benign Prostatic Hyperplasia (BPH)
with mechanism of action
Treatment of BPH is aimed at relieving urinary obstruction,
improving urine flow, reducing symptoms, and preventing complications.
Management is usually stepwise, starting with lifestyle measures and
progressing to medicines and procedures when needed.
Stepwise treatment approach
1
Mild symptoms → Watchful waiting + lifestyle measures
2
Moderate symptoms → Medical therapy
3
Persistent symptoms / enlarged prostate → Combination
therapy
4
Failure of medicines or complications → Minimally invasive
procedure or surgery
1. Watchful waiting and lifestyle modification
Used for men with mild symptoms.
Measures
- Reduce
evening fluid intake
- Limit
caffeine and alcohol
- Timed
voiding / bladder training
- Avoid
excessive decongestants (pseudoephedrine) and some antihistamines
- Weight
reduction and regular exercise
Mechanism
These measures reduce urine production, decrease bladder
irritation, and improve bladder emptying habits, thereby reducing urinary
frequency and nocturia.
2. Alpha-1 adrenergic blockers (first-line drugs)
Common drugs
- Tamsulosin
- Silodosin
- Alfuzosin
- Doxazosin
- Terazosin
Mechanism of action
- Block
α1-adrenergic receptors in the smooth muscle of the prostate, bladder
neck, and prostatic urethra.
- This
causes smooth muscle relaxation, lowering urethral resistance.
Clinical effect
- Improves
urine flow within days to weeks.
- Reduces
hesitancy, weak stream, and incomplete emptying.
- Does
not significantly shrink prostate size.
3. 5-alpha-reductase inhibitors (5-ARIs)
Common drugs
- Finasteride
- Dutasteride
Mechanism of action
- Inhibit
5-alpha-reductase enzyme, which converts testosterone →
dihydrotestosterone (DHT).
- Lower
DHT levels in the prostate.
Clinical effect
- Gradual
shrinkage of prostate tissue.
- Reduces
risk of acute urinary retention and need for surgery.
- Best
for enlarged prostates (>30–40 mL).
- Benefit
appears after 3–6 months.
4. Combination therapy
Example
- Tamsulosin
+ Dutasteride
- Tamsulosin
+ Finasteride
Mechanism
Combines two complementary actions:
|
Drug |
Action |
|
Alpha blocker |
Rapid smooth muscle relaxation |
|
5-ARI |
Long-term prostate shrinkage |
Clinical effect
- Faster
symptom relief plus long-term reduction in disease progression.
- Preferred
in men with moderate–severe symptoms and enlarged prostate.
5. Phosphodiesterase-5 inhibitor
Drug
- Tadalafil
5 mg once daily
Mechanism of action
- Inhibits
PDE-5, increasing cGMP levels.
- Causes
relaxation of smooth muscle in the lower urinary tract, prostate, bladder
neck, and pelvic blood vessels.
Clinical effect
- Improves
urinary symptoms.
- Particularly
useful when BPH coexists with erectile dysfunction.
6. Drugs for predominant storage symptoms
If urgency, frequency, and nocturia persist despite good
urine flow.
A. Antimuscarinic agents
- Solifenacin,
Tolterodine, Oxybutynin
Mechanism
Block muscarinic (M3) receptors in the bladder detrusor
muscle → reduce involuntary bladder contractions.
B. Beta-3 agonist
- Mirabegron
Mechanism
Stimulates β3 receptors in detrusor muscle → bladder
relaxation during filling phase.
Clinical effect
Improves urgency, frequency, and urge incontinence.
7. Management of acute urinary retention
Immediate treatment
- Urethral
catheterisation to drain the bladder.
Followed by
- Start
an alpha blocker and attempt a trial without catheter (TWOC) after a few
days.
Mechanism
Catheter provides immediate decompression; alpha blocker
reduces outlet resistance to facilitate subsequent voiding.
8. Minimally invasive procedures
Used when medicines are inadequate or not tolerated.
|
Procedure |
Mechanism |
|
UroLift |
Implants retract prostate lobes and open urethra
mechanically |
|
Rezūm |
Water-vapour thermal energy causes tissue necrosis and
shrinkage |
|
Prostatic artery embolisation |
Reduces blood supply, leading to prostate shrinkage |
9. Surgical treatment (gold standard for severe BPH)
Indications: recurrent retention, recurrent UTI, bladder
stones, haematuria due to BPH, renal impairment, or severe symptoms despite
medication.
A. TURP — Transurethral resection of the prostate
Mechanism
Resects obstructing prostatic tissue through the urethra,
creating a wider channel.
B. HoLEP — Holmium laser enucleation
Mechanism
Laser enucleates enlarged adenomatous tissue from the
surgical capsule.
C. Laser vaporisation (PVP)
Mechanism
Laser vaporises obstructing tissue.
D. Open or robotic simple prostatectomy
Mechanism
Removes large adenomatous prostate tissue directly, usually
for very large glands.
Quick comparison of drug classes
|
Class |
Mechanism |
Onset |
|
Alpha blockers |
Smooth muscle relaxation |
Days |
|
5-ARIs |
↓ DHT → prostate shrinkage |
Months |
|
Tadalafil |
↑ cGMP smooth muscle relaxation |
Days–weeks |
|
Antimuscarinics |
Block bladder muscarinic receptors |
Days–weeks |
|
Mirabegron |
β3-mediated bladder relaxation |
Days–weeks |
Commonly used drugs in BPH
|
Drug class |
Common drugs |
Main use |
|
Alpha-1 blockers |
Tamsulosin, Silodosin, Alfuzosin, Doxazosin, Terazosin |
Rapid relief of urinary symptoms |
|
5-alpha-reductase inhibitors |
Finasteride, Dutasteride |
Shrink enlarged prostate |
|
PDE-5 inhibitor |
Tadalafil |
BPH with erectile dysfunction |
|
Antimuscarinics |
Solifenacin, Tolterodine, Oxybutynin |
Urgency/frequency symptoms |
|
Beta-3 agonist |
Mirabegron |
Overactive bladder symptoms with BPH |
1. Alpha-1 blockers (most commonly used)
These are usually the first choice for men with bothersome
urinary symptoms.
Tamsulosin
- Most
widely prescribed.
- Better
prostate selectivity, less effect on blood pressure.
Silodosin
- Very
selective for prostate α1A receptors.
- Strong
effect on urine flow.
Alfuzosin
- Good
symptom relief with relatively less ejaculatory dysfunction.
Doxazosin / Terazosin
- Useful
when the patient also has hypertension.
Main action: Relax smooth muscle in the prostate and bladder
neck, improving urine flow within days.
2. 5-alpha-reductase inhibitors
Used when the prostate is significantly enlarged.
Finasteride
- Blocks
type II 5-alpha-reductase.
Dutasteride
- Blocks
type I and type II enzymes.
- Produces
a greater reduction in DHT.
Main action: Reduce DHT levels, gradually shrinking the
prostate over months.
3. Combination therapy (very common in practice)
Common combinations:
- Tamsulosin
+ Dutasteride
- Tamsulosin
+ Finasteride
- Silodosin
+ Dutasteride
Used in men with moderate–severe symptoms and enlarged
prostate.
4. Tadalafil
Dose commonly used
- 5
mg once daily
Particularly useful when BPH coexists with erectile
dysfunction.
5. Drugs for storage symptoms (urgency, frequency,
nocturia)
Added when these symptoms persist despite alpha-blocker
therapy.
Antimuscarinics
- Solifenacin
- Tolterodine
- Oxybutynin
Beta-3 agonist
- Mirabegron
Major brands of these drugs relevant in India with
their Manufacturer.
|
Generic name |
Major Indian brands |
Manufacturer |
|
Tamsulosin |
Urimax, Flotral‑T / other local brands |
Cipla (Urimax) |
|
Silodosin |
Silodal, Silofast |
Sun Pharma (Silodal); other companies for
Silofast |
|
Alfuzosin |
Alfusin, Alfuzosin ER |
Intas Pharmaceuticals (Alfusin) |
|
Doxazosin |
Doxacard |
Cipla |
|
Terazosin |
Hytrine |
Abbott India |
Most commonly used in practice: Urimax
(Tamsulosin) and Silodal (Silodosin).
5‑alpha
reductase inhibitors (reduce prostate size)
|
Generic name |
Major brands |
Manufacturer |
|
Finasteride |
Finast, Finpecia |
Dr. Reddy’s Laboratories (Finast); Cipla
(Finpecia) |
|
Dutasteride |
Dutas, Duprost |
Dr. Reddy’s Laboratories (Dutas); Cipla
(Duprost) |
Very common: Dutas (Dutasteride).
Flower Pollen REGUFLO GenLife
Extract with
Saw Palmetto
Combination
therapy (widely prescribed for moderate–severe BPH)
|
Combination |
Major brands |
Manufacturer |
|
Tamsulosin + Dutasteride |
Urimax‑D, Dutamax‑T |
Cipla (Urimax‑D); other Indian companies for
Dutamax‑T |
|
Silodosin + Dutasteride |
Silodal‑D, Sildoo‑D |
Sun Pharma (Silodal‑D); other Indian
companies for Sildoo‑D |
These combinations are among the most
frequently prescribed BPH products in India.
PDE‑5
inhibitor (BPH with erectile dysfunction)
|
Generic name |
Major brands |
Manufacturer |
|
Tadalafil 5 mg |
Megalis, Tadacip |
Macleods Pharmaceuticals (Megalis); Cipla
(Tadacip) |
Drugs used
when urgency/frequency predominates
Antimuscarinics
|
Generic name |
Major brands |
Manufacturer |
|
Solifenacin |
Soliten, Solicept |
Sun Pharma (Soliten); other companies for Solicept |
|
Tolterodine |
Roliten |
Sun Pharma |
|
Oxybutynin |
Ditropan |
Abbott India |
Beta‑3
agonist
|
Generic name |
Major
brands |
Manufacturer |
|
Mirabegron |
Mirago, Mirabeg |
Intas Pharmaceuticals (Mirago);
other Indian companies for Mirabeg. |
Major Brands
Tamsulosin
Urimax — Cipla
Silodosin
Silodal — Sun Pharma
Dutasteride
Dutas — Dr. Reddy’s
Finasteride
Finast — Dr. Reddy’s
Tamsulosin + Dutasteride
Urimax‑D — Cipla
Silodosin + Dutasteride
Silodal‑D — Sun Pharma
Tadalafil 5 mg
Megalis — Macleods
Solifenacin
Soliten — Sun Pharma
Mirabegron
Mirago — Intas
Important precautions
1. Do not ignore worsening symptoms
Contact your doctor if you develop:
- Sudden
inability to pass urine
- Severe
lower abdominal pain
- Blood
in urine
- Fever
with burning urination
- Recurrent
urinary tract infections
- Swelling
of legs or reduced urine output
These may indicate urinary retention or another
complication.
2. Take medicines exactly as prescribed
- Alpha-blockers
(tamsulosin, silodosin) may cause dizziness; rise slowly from bed or a
chair.
- Do
not stop BPH medicines abruptly without medical advice.
3. Be careful with over-the-counter cold medicines
Avoid or ask a doctor before using medicines containing:
- Pseudoephedrine
- Phenylephrine
- Some
antihistamines (chlorpheniramine, diphenhydramine)
These can tighten the bladder neck and worsen urine flow.
4. Limit unnecessary painkillers
Frequent use of some NSAIDs may worsen fluid retention or
kidney problems in susceptible people.
5. Regular follow-up
Men on long-term treatment should have periodic review of
symptoms, urine flow, and prostate status.
Lifestyle changes that help BPH
Fluid management
During the day
- Drink
adequate water (do not deliberately dehydrate yourself).
In the evening
- Reduce
fluids 2–3 hours before bedtime.
Avoid large volumes at once
- Sip
fluids through the day rather than drinking a litre at one time.
Reduce bladder irritants
Limit especially in the evening:
- Tea
- Coffee
- Energy
drinks
- Cola
drinks
- Alcohol
- Very
spicy foods if they trigger symptoms
These can increase urgency and frequency.
Timed voiding (bladder training)
Try to pass urine every 2–4 hours even if the urge is mild.
This prevents overfilling of the bladder.
Double voiding technique
- Urinate
normally.
- Wait
20–30 seconds.
- Try
to urinate again.
This may reduce residual urine.
Avoid holding urine for long periods
Regularly postponing urination can stretch the bladder and
worsen symptoms.
Physical activity
Aim for at least 30 minutes of moderate exercise most days.
Helpful activities:
- Brisk
walking
- Cycling
with a comfortable seat
- Swimming
- Yoga
or stretching
Exercise is associated with better urinary symptoms and
weight control.
Weight management
Excess abdominal weight is linked with worse BPH symptoms.
Even modest weight loss can help.
Prevent constipation
A full rectum can increase pressure on the bladder outlet.
Increase:
- Fruits
- Vegetables
- Whole
grains
- Water
intake during the day
Stay physically active.
Pelvic floor relaxation
When urinating:
- Sit
down if that helps you relax.
- Take
your time.
- Avoid
straining hard.
Excess straining can worsen pelvic floor tension.
Sleep-related measures
- Empty
your bladder immediately before going to bed.
- Elevate
the legs for an hour in the evening if you have leg swelling; this can
reduce night-time urination.
Habits that often worsen BPH symptoms
|
Habit |
Effect |
|
Excess evening fluids |
More night-time urination |
|
Tea/coffee late evening |
Urgency and frequency |
|
Alcohol at night |
Nocturia and poor sleep |
|
Long periods without urinating |
Bladder overdistension |
|
Constipation |
Worse obstruction symptoms |
|
Physical inactivity |
More severe LUTS |
|
Obesity |
Increased symptom burden |
A simple daily routine for a man with BPH
Morning
Walk 20–30 min; take prescribed medicine after breakfast if
advised.
Daytime
Drink water regularly; avoid holding urine; void every 3–4
h.
Evening
Reduce tea/coffee/alcohol; lighter dinner; manage
constipation.
Before bed
Limit fluids for 2–3 h beforehand; urinate just before
sleeping.
When lifestyle measures are enough
Men with mild symptoms often improve substantially with
these measures alone. If symptoms remain bothersome after several weeks,
medical treatment is usually considered.
Key take-home message
The three lifestyle changes with the greatest day-to-day
benefit are:
- Reduce
evening fluids
- Limit
caffeine and alcohol
- Do
not hold urine; use timed voiding and double voiding
Medicines used for Benign Prostatic Hyperplasia with
their brand names in India
1. Alpha-1
blockers (first-line medicines)
·
These relax the prostate and bladder neck and
give relatively quick symptom relief.
|
Generic medicine |
Common Indian brands |
Manufacturer |
|
Tamsulosin 0.4 mg |
Urimax, Veltam, Contiflo Icon, Tamsulin |
Cipla; Intas; Sun Pharma; Ipca |
|
Silodosin 8 mg |
Silodal, Rapilif, Sildoo, Prostagard,
Maxvoid |
Sun Pharma; Ipca; Dr. Reddy’s; Aristo; Alkem |
|
Alfuzosin 10 mg |
Flotral, Alfusin, Alfoo |
Sun Pharma; Cipla; Dr. Reddy’s |
·
Most commonly prescribed: Urimax (Tamsulosin)
and Silodal (Silodosin). 1mg BPH products listing .
·
2. 5-alpha reductase
inhibitors (reduce prostate size)
·
Used when the prostate is enlarged.
|
Generic medicine |
Common Indian brands |
Manufacturer |
|
Dutasteride 0.5 mg |
Dutas, Duprost, Dutamax |
Dr. Reddy’s; Cipla; Galcare |
|
Finasteride 5 mg |
Finast, Finalo, Finpecia |
Torrent; Intas; Cipla |
·
Very common: Dutas (Dutasteride). 1mg page 2 .
·
3. Combination medicines
(widely used in moderate–severe BPH)
·
These combine an alpha-blocker with
dutasteride.
|
Combination |
Brand |
Manufacturer |
|
Tamsulosin + Dutasteride |
Urimax-D, Veltam Plus, Flodart Plus,
Flokind-D, Tamdura |
Cipla; Intas; Aristo; Mankind; Sun Pharma |
|
Silodosin + Dutasteride |
Silodal-D, Prostagard-D, Geripod-D |
Sun Pharma; Aristo; Alembic |
·
Urimax-D contains Tamsulosin 0.4 mg +
Dutasteride 0.5 mg and is marketed by Cipla. Apollo Urimax-D .
·
4. Medicine used when BPH
coexists with erectile dysfunction
|
Generic medicine |
Common brands |
Manufacturer |
|
Tadalafil 5 mg daily |
Megalis, Tadacip |
Macleods; Cipla |
·
5. Medicines added when
urgency/frequency is prominent
·
Antimuscarinics
|
Generic |
Brand |
Manufacturer |
|
Solifenacin |
Soliten |
Sun Pharma |
|
Tolterodine |
Roliten |
Sun Pharma |
·
Beta-3 agonist
|
Generic |
Brand |
Manufacturer |
|
Mirabegron |
Mirago |
Intas |
·
Sun Pharma lists Soliten, Roliten, Silodal,
Silodal-D, and Tamdura in its Indian urology portfolio. Sun Pharma India
products .
SInce 2011, REGUFLO (GenLife) a Nutraceutical that has enough clinical evidence is being widely used in BPH cases by top Urologists with excellent results. Regulo is formulated using Flower Pollen Extract and Saw Palmetto (both are imported ingredients) which have synergistic effect and provides immediate relief and long-term prevention without any side effects. Hence, patient Quality of Life is preserved.
DISCLAIMER
- All details provided regarding diseases and medicines have been collated
from sources in the public domain and are for general awareness purposes only.
This information does not constitute medical advice. It is strongly advised not
to depend on online information and to always consult a qualified Medical
Doctor for a better understanding of any disease, its symptoms, and its
treatment. DO NOT SELF MEDICATE under any circumstances. Medicines should only
be consumed as prescribed by a registered medical practitioner; a valid
prescription may be required for scheduled drugs as per applicable Indian law.
GENHEALTH shall not be held responsible for any action taken based on the
information provided on this platform. In case of a medical emergency, please
contact your nearest hospital or dial emergency services immediately.